Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Piperidine, pyrrolidine and pyrroline derivatives selectively affect 5-HT function

Feb. 2, 2000

New series from Lilly affecting serotonergic pathways

Feb. 1, 2000

Naltriben: potential new pharmacotherapeutic for reducing alcohol intake

Jan. 17, 2000

Pharmacological profile of SR-141716A, a selective CB1 antagonist, further characterized

Dec. 29, 1999

Brain cocaine receptor ligands from RTI with favorable properties for pharmaceutical, imaging use

Dec. 28, 1999

New agent for treating cocaine dependency in development at RBI

Dec. 22, 1999

Preclinical studies validate Nabi's novel approach to treating and preventing nicotine addiction

Dec. 20, 1999

Novartis reports setbacks and advances in the development of new chelating agents

Dec. 8, 1999

Glaxo Wellcome's Zyban approved in The Netherlands for smoking cessation

Dec. 3, 1999

Neuronal nicotinic acetylcholine receptor ligands in early development at Pfizer

Nov. 30, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...